BCG vaccine nesting birds and rusted electrical conduits. The resulting closure of the plant for over two years resulting in shortages of bladder cancer and tuberculosis vaccines. On October 29, 2014 Health Canada gave the permission for Sanofi to resume production of BCG. The global supply situation was analyzed in 2017 and concluded that the global supply is sufficient to meet forecasted BCG vaccine demand but risks for shortages remain mainly due to supply concentration. A weakened strain of bovine tuberculosis bacillus, "Mycobacterium bovis" is specially subcultured in a culture medium, usually Middlebrook 7H9. Some BCG vaccines are freeze dried and become
Inoculation needle is uncapped. The open end of the uncapped slant culture is then flamed. The slant will be positioned to move up the needle until the inoculation needle tip lightly come into contact with the base surface of the sterile media. The inoculation needle inoculates the sterile agar by the manipulation of the media so that the needle tip grazes the agar surface in a zigzag pattern. Aseptic technique is then applied to the withdrawn inoculation needle. Inoculation of a plate culture is done through the streaking technique to make a streak plate. After lifting the lid so that it hovers